CELH
Celsius Holdings, Inc.
CELH has the edge over DLTR overall, supported by stronger fundamentals and stronger modeled upside.
DLTR
Dollar Tree, Inc.
DLTR has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DLTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
DLTR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
DLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $139 | -1.9% |
| Current | 17x | $141 | — |
| Forward | 19x | $141 | — |
| Fair | 22x | $176 | +25% |
| Expensive | 26x | $212 | +50% |
Historical ranges are pointers, not guarantees.
DLTR has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over DLTR on the outlook, with more favorable valuation expectations.
DLTR Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for DLTR, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
DLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.45 | -8.7% |
| Q3 2026 | $8.16 | +$21.73 |
| Q2 2026 | $6.37 | +$20.23 |
| Q1 2026 | $6.22 | +$20.31 |
| Q4 2025 | -$13.45 | -$8.75 |
| Q3 2025 | -$13.57 | -$8.76 |
| Q2 2025 | -$13.86 | -$9.34 |
| Q1 2025 | -$14.09 | -$9.54 |
| Q4 2024 | -$4.70 | -189% |
DLTR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over DLTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over DLTR on profitability, with a higher operating margin.
DLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.9B | +7% |
| Q2 2026 | $5B | +7.2% |
| Q1 2026 | $5.5B | +9.1% |
| Q4 2025 | $4.8B | -37% |
| Q3 2025 | $4.6B | -38% |
| Q2 2025 | $4.6B | -39% |
| Q1 2025 | $5B | -42% |
| Q4 2024 | $7.6B | +3.5% |
DLTR's revenue is recovering but still below its 2024 peak: $4.9B last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +9.1 points |
| Q2 2026 | 9.5% | +1.2 points |
| Q1 2026 | 13% | +2.7 points |
| Q4 2025 | 7.2% | +2.8 points |
| Q3 2025 | 5% | +2.3 points |
| Q2 2025 | 8.3% | +2.8 points |
| Q1 2025 | 10% | +32 points |
| Q4 2024 | 4.4% | +0.3 points |
DLTR's operating margin was 14% last quarter, up 9.1 points from the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
DLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $675.2M | +4228% |
| Q2 2026 | $391.5M | +202% |
| Q1 2026 | $968.5M | +92% |
| Q4 2025 | -$57.1M | -116% |
| Q3 2025 | $15.6M | +$209.4M |
| Q2 2025 | $129.7M | -42% |
| Q1 2025 | $503.9M | +7% |
| Q4 2024 | $359.2M | +$394.8M |
DLTR has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
DLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -6.5M shares |
| 1 year | -8.1% | -16.9M shares |
| 3 years | -13% | -29.6M shares |
| 5 years | -17% | -38.6M shares |
| Available history | -20% | -46.6M shares |
DLTR has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $623.1M |
| Q2 2026 | $585.8M |
| Q1 2026 | $236M |
| Q4 2025 | $387.8M |
| Q3 2025 | $496.5M |
| Q2 2025 | $427.7M |
| Q1 2025 | — |
| Q4 2024 | — |
DLTR spent $1.8B buying back its own shares over the past year, up 98% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
DLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 0.7x | Very low |
DLTR's net debt is less than a year of its operating earnings (EBITDA).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
DLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 73.9 | Neutral |
DLTR's weekly RSI is 64 (neutral) and its Stochastic is 74 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
DLTR PE vs Consumer Defensive Sector
| Metric | DLTR | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 19x | 11% below |
| PE % | 18 | 18 | Same percentile |
DLTR has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
DLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $125.1 | 13% above |
| 20 week MA | $125.2 | 13% above |
| 50 week MA | $119.4 | 18% above |
| 100 week MA | $104.6 | 35% above |
| 200 week MA | $112.3 | 26% above |
DLTR has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
DLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.8 | $109.0 | +17% |
| 2021 | $109.0 | $137.0 | +26% |
| 2022 | $137.0 | $141.9 | +3.6% |
| 2023 | $141.9 | $142.1 | +0.1% |
| 2024 | $142.1 | $76.0 | -47% |
| 2025 | $76.0 | $124.0 | +63% |
| 2026 YTD | $124.0 | $141.3 | +14% |
DLTR has the edge over CELH on returns for 2026, with the stronger performance.